NEOG

NEOG

USD

Neogen Corporation Common Stock

$5.160+0.040 (0.781%)

Цена в режиме реального времени

Healthcare
Diagnostics & Research
Соединенные Штаты

График цен

Ключевые показатели

Рыночные показатели
Фундаментальные показатели компании
Статистические данные торговли

Рыночные показатели

Открытие

$5.120

Максимум

$5.245

Минимум

$5.025

Объем

0.01M

Фундаментальные показатели компании

Рыночная капитализация

1.1B

Отрасль

Diagnostics & Research

Страна

United States

Статистические данные торговли

Средний объем

5.24M

Биржа

NMS

Валюта

USD

52-недельный диапазон

Минимум $3.87Текущая $5.160Максимум $18.58

Отчет об анализе ИИ

Последнее обновление: 28 апр. 2025 г.
Сгенерировано ИИИсточник данных: Yahoo Finance, Bloomberg, SEC

NEOG (Neogen Corporation Common Stock): What's Happening and What to Watch

Stock Symbol: NEOG Generate Date: 2025-04-28 07:04:53

Alright, let's break down what's been going on with Neogen stock lately. Think of this as getting the lowdown from a friend who's been keeping an eye on things.

The Recent News Buzz

So, what's the talk around Neogen? It's been a bit of a mixed bag, leaning towards the tough side recently.

We saw a couple of analysts, specifically Piper Sandler, cut their price targets on the stock. Not just once, but twice in April, bringing their target way down from $13 to $6.5, and then even further to $5. Guggenheim also lowered their target, though they still kept a "Buy" rating, just dropping their target from $15 to $13. When analysts slash targets like that, it usually signals they see less potential for the stock price to go up in the near future than they did before. That's generally not great news for investors.

Then came the company's third-quarter results. They reported a net loss of $11 million, or $0.05 per share. Nobody likes seeing a loss on the bottom line. However, they also mentioned "Adjusted Net Income" and "Adjusted EBITDA" which looked positive ($20.9 million and $48.5 million, respectively). Companies often use adjusted numbers to show performance without certain one-time items, but the official net loss is still what it is.

Adding to the changes, Neogen announced their CEO is transitioning out, and they're looking for a new one. A change at the top can create uncertainty for a bit while everyone waits to see the new direction.

On a more positive note, they announced they're selling their cleaners and disinfectants business. This could mean they're focusing more on their core food and animal safety testing areas. They also successfully refinanced a big chunk of their debt, which is a smart financial move to manage their borrowing costs.

Putting it together, the news flow has featured some clear negatives like analyst downgrades and a net loss, alongside potentially positive strategic moves like selling a business and managing debt. The CEO change adds a layer of "wait and see."

Checking the Price Action

Now, let's look at what the stock price has actually been doing. If you look at the last few months, it's been a pretty rough ride downhill. Back in late January, shares were trading around $11-$12. They drifted lower through February and March.

Then, around April 9th, something big happened. The stock took a massive dive, dropping sharply in a single day. This lines up exactly with the news about their Q3 results and the CEO transition. Since that big fall, the price has been bouncing around in a much lower range, mostly between $4.50 and $5.70. The last price we have is around $5.16.

So, the price chart clearly shows the market reacted strongly and negatively to the recent financial and leadership news, pushing the stock down significantly to these lower levels.

Interestingly, the AI prediction for the next couple of days suggests a slight upward movement from here. It sees a small gain today (0.00% - essentially flat), then around a 2.9% jump the next day, and another 4.2% the day after that. This hints the AI thinks the stock might be finding a floor around these prices, at least in the very short term.

What This Might Mean & Some Ideas

Based on everything – the analyst cuts, the net loss, the CEO change, the price crashing, but also the business sale, debt refinancing, and the AI seeing a potential bounce – what's the takeaway?

The fundamental picture from the recent news (earnings, analyst views) looks challenging, which explains the big drop in the stock price. However, the stock is now trading at a much lower level. The AI prediction, along with some of the underlying data in the recommendation (like technicals suggesting it's near support and seeing buying volume, plus a summary mentioning positive analyst sentiment and a higher average price target from some analysts, despite the cuts we saw), suggests there might be a chance for the stock to stabilize or even tick up from these depressed levels in the short term.

Given the sharp decline and the AI/recommendation data pointing to potential short-term upside from here, one way to look at this is that the stock might be oversold after the bad news.

  • Apparent Near-Term Leaning: The situation seems to lean towards a potential 'accumulate' or 'watch for entry' scenario at these lower price levels, driven more by the stock's significant drop and the AI/technical signals than the recent fundamental news itself. The news was bad, the price reacted, and now the question is if it's too low.
  • Potential Entry Consideration: If you were considering this stock, the current price area, maybe around $5.15 to $5.20 (which aligns with the recommendation data's suggested entry points), could be a level to watch. This is near recent lows and where the AI sees potential for a bounce.
  • Potential Exit/Stop-Loss Consideration: To manage risk, one potential stop-loss level could be set below recent significant lows, perhaps around $4.65, as suggested by the recommendation data. This is a level where if the stock falls below it, the recent bounce idea might be wrong, and it could head lower. For taking profits, the recommendation data suggests a level around $5.69, which is near the higher end of the trading range the stock has been in since the big drop.

Remember, these are just potential ideas based on the data provided, not guarantees. The stock has been volatile.

A Little More About Neogen

Just to keep in mind, Neogen is a company focused on food and animal safety. They make tests and products to check for bad stuff in food and help keep animals healthy. So, news about their testing business, food industry trends, or animal health issues are particularly relevant to how the company performs. The sale of the cleaners business means they're narrowing their focus a bit within this space.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock markets are risky, and prices can go down as well as up. You should always do your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

Связанные новости

Analyst Upgrades

Piper Sandler Maintains Neutral on Neogen, Lowers Price Target to $5

Piper Sandler analyst David Westenberg maintains Neogen with a Neutral and lowers the price target from $6.4 to $5.

Просмотреть больше
Piper Sandler Maintains Neutral on Neogen, Lowers Price Target to $5
BusinessWire

Neogen Announces Sale of Cleaners & Disinfectants Business

Neogen Corporation (NASDAQ:NEOG), an innovative leader in food safety solutions, announced today it has entered into a definitive agreement to sell its global cleaners and disinfectants business to Kersia Group

Просмотреть больше
Neogen Announces Sale of Cleaners & Disinfectants Business
Analyst Upgrades

Piper Sandler Maintains Neutral on Neogen, Lowers Price Target to $6.5

Piper Sandler analyst David Westenberg maintains Neogen with a Neutral and lowers the price target from $13 to $6.5.

Просмотреть больше
Piper Sandler Maintains Neutral on Neogen, Lowers Price Target to $6.5
Analyst Upgrades

Guggenheim Maintains Buy on Neogen, Lowers Price Target to $13

Guggenheim analyst Subbu Nambi maintains Neogen with a Buy and lowers the price target from $15 to $13.

Просмотреть больше
Guggenheim Maintains Buy on Neogen, Lowers Price Target to $13
BusinessWire

Neogen Announces Third-Quarter 2025 Results

Revenue of $221.0 million. Net loss of $11.0 million; $(0.05) per diluted share. Adjusted Net Income1 of $20.9 million; $0.10 per diluted share. Adjusted EBITDA1 of $48.5 million. Updating full-year

Просмотреть больше
Neogen Announces Third-Quarter 2025 Results
BusinessWire

Neogen® Announces CEO Transition

Board has Formed Search Committee and Engaged Leading Executive Search Firm Neogen® Corporation (NASDAQ:NEOG), an innovative leader in food safety solutions, today announced that John Adent, the Company's CEO and

BusinessWire

Neogen® Announces Refinancing of Term Loan and Revolving Credit Facility

Neogen® Corporation (NASDAQ:NEOG), an innovative leader in food safety solutions, announced today the successful refinancing of the remaining $550 million principal of its original $650 million term loan, as well

Прогноз ИИBeta

Рекомендация ИИ

Бычий

Обновлено в: 28 апр. 2025 г., 04:16

МедвежийНейтральныйБычий

68.6% Уверенность

Риск и торговля

Уровень риска3/5
Средний риск
Подходит для
СтоимостьАгрессивный
Руководство по торговле

Точка входа

$5.17

Взять прибыль

$5.69

Остановить убытки

$4.65

Ключевые факторы

PDI 11.2 выше MDI 9.8 с ADX 8.8, что предполагает бычий тренд
Текущая цена очень близка к уровню поддержки ($5.15), что предполагает сильную возможность покупки
Объем торгов в 6.4 раз превышает среднее значение (70,205), что указывает на чрезвычайно сильное покупательское давление
MACD 0.0018 ниже сигнальной линии 0.0032, что указывает на медвежье пересечение

Оставаться в курсе

Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.